NEW: Express access to COVID-19 vaccine record is now available.

The MyHealth.Alberta.ca Network showcases trusted, easy-to-use health and wellness resources from Alberta Health Services and Alberta-based partner organizations. The network is led by MyHealth.Alberta.ca, Alberta’s source for consumer health information. Our partners are committed to helping Albertans better manage their health and wellbeing. Health experts across Alberta make sure that the information on these sites is accurate and up-to-date. Our partners include

MyHealth.Alberta.ca Network
Health Information and Tools >  Photodynamic Therapy for Age-Related Macular Degeneration

Main Content

Photodynamic Therapy for Age-Related Macular Degeneration

Treatment Overview

Photodynamic therapy (PDT) is a treatment for wet age-related macular degeneration (wet AMD). It is not used to treat dry AMD.

Photodynamic therapy may be recommended if you can't have injections of medicines to treat your AMD or if these injections don't work.

In photodynamic therapy, a light-sensitive medicine called verteporfin (Visudyne) is injected into the bloodstream. The medicine collects in the abnormal blood vessels under the macula. Laser light is then shone into the eye, which activates the medicine and causes it to create blood clots that block the abnormal blood vessels. By sealing the leaky blood vessels, photodynamic therapy slows down central vision loss.

Photodynamic therapy takes about 20 minutes and may be done in a doctor's office or eye clinic.

Information about Photodynamic Therapy for Age-Related Macular Degeneration

Current as of: November 16, 2023

Author: Ignite Healthwise, LLC Staff

Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

This information does not replace the advice of a doctor. Ignite Healthwise, LLC, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

Information about Photodynamic Therapy for Age-Related Macular Degeneration

Current as of: November 16, 2023

Author: Ignite Healthwise, LLC Staff

Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.